Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:3544-3552
Published online before print November 29, 2004, doi: 10.1161/01.CIR.0000148825.99184.50
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
110/23/3544    most recent
01.CIR.0000148825.99184.50v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hollander, J. M.
Right arrow Articles by Dillmann, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hollander, J. M.
Right arrow Articles by Dillmann, W. H.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
*Genetics Home Reference
Related Collections
Right arrow Contractile function
Right arrow Genetically altered mice
Right arrow Oxidant stress

(Circulation. 2004;110:3544-3552.)
© 2004 American Heart Association, Inc.


Heart Failure

Overexpression of Wild-Type Heat Shock Protein 27 and a Nonphosphorylatable Heat Shock Protein 27 Mutant Protects Against Ischemia/Reperfusion Injury in a Transgenic Mouse Model

John M. Hollander, PhD; Jody L. Martin, PhD; Darrell D. Belke, PhD; Brian T. Scott, BS; Eric Swanson, BS; Vignesh Krishnamoorthy, BS; Wolfgang H. Dillmann, MD

From the Department of Medicine (J.M.H., D.D.B., B.T.S., E.S., W.H.D.), University of California, San Diego; the Cardiovascular Institute (J.L.M.), Loyola University Medical Center, Maywood, Ill; and the Department of Physiology (V.K.), Loyola University, Maywood, Ill.

Correspondence to Wolfgang H. Dillmann, MD, University of California, San Diego, Department of Medicine, 9500 Gilman Dr, La Jolla, CA 92093-0618. E-mail wdillman{at}ucsd.edu

Received December 5, 2003; de novo received July 20, 2004; revision received August 31, 2004; accepted September 8, 2004.

Background— The small heat shock protein 27 (hsp27) increases in expression with ischemia/reperfusion (I/R) insult in the heart. One feature of the small hsps is their ability to oligomerize and form intracellular aggregates. Oligomerization pattern is governed by the phosphorylation state of the protein that may influence their ability to protect against cellular stresses.

Methods and Results— We generated transgenic (tg) mice that overexpress a wild-type human hsp27 (hsp27tg) protein or a mutant hsp27 protein (mut-hsp27tg), in which serine residues (aa15, aa78, and aa82) were replaced by alanine residues, rendering them incapable of phosphorylation. Using a Langendorff perfusion model and an intraventricular balloon, we subjected hearts to 20 minutes of ischemia followed by 1 hour of reperfusion. During reperfusion, negative and positive pressure derivatives as well as developed pressures were significantly higher in both hsp27tg and mut-hsp27tg compared with control (P<0.01) mice, with no significant difference between hsp27tg and mut-hsp27tg. Creatine kinase release during reperfusion was higher in control compared with both hsp27tg and mut-hsp27tg (P<0.05). Malondialdehyde content as well as protein oxidation products were lower in mut-hsp27tg compared with control (P<0.05). hsp27tg hearts possessed oligomers that ranged in size from small to large, whereas mut-hsp27tg hearts contained no small oligomers.

Conclusions— These results indicate that in a tg mouse model, overexpression of either wild-type hsp27 or a nonphosphorylatable hsp27 mutant was equally capable of protecting the heart from I/R injury. Furthermore, the phosphorylation status of hsp27 may influence its ability to decrease oxidative stress.


Key Words: ischemia • reperfusion • free radicals




This article has been cited by other articles:


Home page
EndocrinologyHome page
T. Dai, M. Patel-Chamberlin, R. Natarajan, I. Todorov, J. Ma, J. LaPage, L. Phillips, C. C. Nast, D. Becerra, P. Chuang, et al.
Heat Shock Protein 27 Overexpression Mitigates Cytokine-Induced Islet Apoptosis and Streptozotocin-Induced Diabetes
Endocrinology, July 1, 2009; 150(7): 3031 - 3039.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. R. Dabkowski, C. L. Williamson, V. C. Bukowski, R. S. Chapman, S. S. Leonard, C. J. Peer, P. S. Callery, and J. M. Hollander
Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations
Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H359 - H369.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Laczy, B. G. Hill, K. Wang, A. J. Paterson, C. R. White, D. Xing, Y.-F. Chen, V. Darley-Usmar, S. Oparil, and J. C. Chatham
Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H13 - H28.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Rayner, Y.-X. Chen, M. McNulty, T. Simard, X. Zhao, D. J. Wells, J. de Belleroche, and E. R. O'Brien
Extracellular Release of the Atheroprotective Heat Shock Protein 27 Is Mediated by Estrogen and Competitively Inhibits acLDL Binding to Scavenger Receptor-A
Circ. Res., July 18, 2008; 103(2): 133 - 141.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Sabri, K. Rafiq, R. Seqqat, M. A. Kolpakov, R. Dillon, and L. J. Dell'italia
Sympathetic Activation Causes Focal Adhesion Signaling Alteration in Early Compensated Volume Overload Attributable to Isolated Mitral Regurgitation in the Dog
Circ. Res., May 9, 2008; 102(9): 1127 - 1136.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Havasi, Z. Li, Z. Wang, J. L. Martin, V. Botla, K. Ruchalski, J. H. Schwartz, and S. C. Borkan
Hsp27 Inhibits Bax Activation and Apoptosis via a Phosphatidylinositol 3-Kinase-dependent Mechanism
J. Biol. Chem., May 2, 2008; 283(18): 12305 - 12313.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
X.-Y. Lu, L. Chen, X.-L. Cai, and H.-T. Yang
Overexpression of heat shock protein 27 protects against ischaemia/reperfusion-induced cardiac dysfunction via stabilization of troponin I and T
Cardiovasc Res, April 25, 2008; (2008) cvn091v2.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. D. Venkatakrishnan, K. Dunsmore, H. Wong, S. Roy, C. K. Sen, A. Wani, J. L. Zweier, and G. Ilangovan
HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1736 - H1744.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Avkiran, A. J. Rowland, F. Cuello, and R. S. Haworth
Protein Kinase D in the Cardiovascular System: Emerging Roles in Health and Disease
Circ. Res., February 1, 2008; 102(2): 157 - 163.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. T. Clements, N. R. Sodha, J. Feng, S. Mieno, M. Boodhwani, B. Ramlawi, C. Bianchi, and F. W. Sellke
Phosphorylation and translocation of heat shock protein 27 and alphaB-crystallin in human myocardium after cardioplegia and cardiopulmonary bypass.
J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1461 - 1470.e3.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W. Huang, J. B. Fileta, T. Filippopoulos, A. Ray, A. Dobberfuhl, and C. L. Grosskreutz
Hsp27 Phosphorylation in Experimental Glaucoma
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4129 - 4135.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
L. Liu, X. Zhang, B. Qian, X. Min, X. Gao, C. Li, Y. Cheng, and J. Huang
Over-expression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice
Eur J Heart Fail, August 1, 2007; 9(8): 762 - 769.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
T. Yamaguchi, H. Arai, N. Katayama, T. Ishikawa, K. Kikumoto, and Y. Atomi
Age-Related Increase of Insoluble, Phosphorylated Small Heat Shock Proteins in Human Skeletal Muscle
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2007; 62(5): 481 - 489.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Zourlidou, T. Gidalevitz, M. Kristiansen, C. Landles, B. Woodman, D. J. Wells, D. S. Latchman, J. de Belleroche, S. J. Tabrizi, R. I. Morimoto, et al.
Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation
Hum. Mol. Genet., May 1, 2007; 16(9): 1078 - 1090.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. D. Coaxum, T. M. Griffin, J. L. Martin, and R. Mestril
Influence of PKC-{alpha} overexpression on HSP70 and cardioprotection
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2220 - H2226.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Fulop, Z. Zhang, R. B. Marchase, and J. C. Chatham
Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2227 - H2236.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Sakamoto, T. Minamino, H. Toko, Y. Kayama, Y. Zou, M. Sano, E. Takaki, T. Aoyagi, K. Tojo, N. Tajima, et al.
Upregulation of Heat Shock Transcription Factor 1 Plays a Critical Role in Adaptive Cardiac Hypertrophy
Circ. Res., December 8, 2006; 99(12): 1411 - 1418.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. D. Venkatakrishnan, A. K. Tewari, L. Moldovan, A. J. Cardounel, J. L. Zweier, P. Kuppusamy, and G. Ilangovan
Heat shock protects cardiac cells from doxorubicin-induced toxicity by activating p38 MAPK and phosphorylation of small heat shock protein 27
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2680 - H2691.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Maulik
Effect of p38 MAP kinase on cellular events during ischemia and reperfusion: possible therapy
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2302 - H2303.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Okada, H. Otani, Y. Wu, S. Kyoi, C. Enoki, H. Fujiwara, T. Sumida, R. Hattori, and H. Imamura
Role of F-actin organization in p38 MAP kinase-mediated apoptosis and necrosis in neonatal rat cardiomyocytes subjected to simulated ischemia and reoxygenation
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2310 - H2318.
[Abstract] [Full Text] [PDF]